Suppression of Insulin-Like Growth Factor Acid-Labile Subunit Expression—A Novel Mechanism for Deoxynivalenol-Induced Growth Retardation

The Acid-Labile Subunit Is Required for Full Effects of Exogenous Growth Hormone on Growth and Carbohydrate Metabolism

(2009) Iori Ueki et al.   ENDOCRINOLOGY

Induction of Suppressors of Cytokine Signaling by the Trichothecene Deoxynivalenol in the Mouse

(2009) Chidozie J. Amuzie et al.   TOXICOLOGICAL SCIENCES

Growth Hormone Regulation of Insulin-Like Growth Factor-I Gene Expression May Be Mediated by Multiple Distal Signal Transducer and Activator of Transcription 5 Binding Sites

(2008) Satyanaryana Eleswarapu et al.   ENDOCRINOLOGY

Deoxynivalenol: Rationale for development and application of a urinary biomarker

(2008) Paul C. Turner et al.   Food Additives and Contaminants Part A-Chemistry Analysis Control Exposure & Risk Assessment

Primary Acid-Labile Subunit Deficiency due to RecessiveIGFALSMutations Results in Postnatal Growth Deficit Associated with Low Circulating Insulin Growth Factor (IGF)-I, IGF Binding Protein-3 Levels, and Hyperinsulinemia

(2008) Karen E. Heath et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Deoxynivalenol Induces p38 Interaction with the Ribosome in Monocytes and Macrophages

(2008) Hee Kyong Bae et al.   TOXICOLOGICAL SCIENCES

Tissue distribution and proinflammatory cytokine induction by the trichothecene deoxynivalenol in the mouse: Comparison of nasal vs. oral exposure

(2008) Chidozie J. Amuzie et al.   TOXICOLOGY

Immunochemical assessment of deoxynivalenol tissue distribution following oral exposure in the mouse

(2008) James J. Pestka et al.   TOXICOLOGY LETTERS

Quantitative ontogeny of murine insulin-like growth factor (IGF)-I, IGF-binding protein-3 and the IGF-related acid-labile subunit

(2007) David L. Hwang et al.   GROWTH HORMONE & IGF RESEARCH